This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Cockburn, I. & Henderson, R. Public-Private Interaction and the Productivity of Pharmaceutical Research. National Bureau of Economic Research (NBER) Working Paper 6018 (NBER, Cambridge, MA, 1997).
Powell, W.W., Korput, K.W. & Smith-Doerr, L. Administr. Sci. Quart. 41, 116–145 (1996).
Murray, F. Res. Policy 31, 1389–1403 (2002).
Henderson, R., Orsenigo, L. & Pisano, G.P. in Sources of Industrial Leadership, Studies of Seven Industries (eds. Mowery, D. & Nelson, R.) 267–311 (Cambridge University Press, Cambridge, UK, 1999).
McKelvey, M. Evolutionary Innovations, the Business of Biotechnology (Oxford University Press, Oxford, 1996).
Zucker, L.G. & Darby, M.R. Proc. Natl. Acad. Sci. USA 93, 12709–12716 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kneller, R. The origins of new drugs. Nat Biotechnol 23, 529–530 (2005). https://doi.org/10.1038/nbt0505-529
Issue Date:
DOI: https://doi.org/10.1038/nbt0505-529
This article is cited by
-
The importance of new companies for drug discovery: origins of a decade of new drugs
Nature Reviews Drug Discovery (2010)
-
Can literature analysis identify innovation drivers in drug discovery?
Nature Reviews Drug Discovery (2009)
-
Leveraging biotech's drug discovery expertise for neglected diseases
Nature Biotechnology (2009)
-
Erratum: Corrigendum: The origins of new drugs
Nature Biotechnology (2005)
-
Finding improved medicines: the role of academic–industrial collaboration
Nature Reviews Drug Discovery (2005)